Search Results - "Antonova, M S"

Surgical treatment of patients with abdominal sepsis taking into account the prediction of the implementation of re-operations by Kryvoruchko, I. A., Antonova, M. S., Yevtushenko, O. V., Andreieshchev, S. A.

“…Objective. The investigation objective was improvement of the surgical treatment results in patients, suffering аbdominal sepsis, using individualized tactics…”
Get full text

Assessment of risk of the development of complications after abdominal aorta shunting by Kobak, A E, Lembrikov, I A, Nemkov, A S, Tokarevich, K K, Stekanov, P A, Lavrov, R Iu, Antonova, M S

Get full text

Structure and mechanical properties of Ag–Cu films prepared by vacuum codeposition of Au and Cu by Kushchev, S. B., Bosykh, M. A., Kannykin, S. V., Kostyuchenko, A. V., Soldatenko, S. A., Antonova, M. S.

“…We have studied in detail the structure formation process in Ag–Cu films in the course of vacuum deposition of the metals, followed by thermal annealing, and…”
Get full text

Abdominal Compartment Syndrome in Patients with Abdominal Sepsis by I. A. Kryvoruchko, M. S. Antonova, O. A. Tonkoglas, S.-K. T. Goni

“…Investigations were carried out in 53 patients who were operated on in 2015 about abdominal sepsis (AS). All patients were assigned according the severity of…”
Get full text

Abdominal Compartment Syndrome in Patients with Abdominal Sepsis by I. A. Kryvoruchko, M. S. Antonova, O. A. Tonkoglas, S.-K. T. Goni

“…Investigations were carried out in 53 patients who were operated on in 2015 about abdominal sepsis (AS). All patients were assigned according the severity of…”
Get full text

Photoactivated nanocrystallization and hardness of Fe78P20Si2 alloy by Antonova, M. S., Belonogov, E. K., Boryak, A. V., Vavilova, V. V., Ievlev, V. M., Kannykin, S. V., Palii, N. A.

“…The structural changes induced in an amorphous Fe 78 P 20 Si 2 alloy by heat treatment and lamp processing have been compared using X-ray diffraction. The…”
Get full text

Modern methods of stimulation of angiogenesis in patients with critical limb ischemia (review) by I. A. Kryvoruchko, S. K.-T. Goni, M. S. Antonova, M. A. Sykal, U. M. Voronaja, M. A. Alexandrov, N. V. Lola

“…The term "critical ischemia of extremities" (critical limb ischemia) was first introduced by P.R.F. Bell in 1982 to refer to a group of diseases accompanied by…”
Get full text

Modern methods of stimulation of angiogenesis in patients with critical limb ischemia (review) by I. A. Kryvoruchko, S. K.-T. Goni, M. S. Antonova, M. A. Sykal, U. M. Voronaja, M. A. Alexandrov, N. V. Lola

“…The term "critical ischemia of extremities" (critical limb ischemia) was first introduced by P.R.F. Bell in 1982 to refer to a group of diseases accompanied by…”
Get full text

Methodical issues of the monitoring for ammonium in indoors air by Iakubova, I Sh, Dadaly, Yu V, Mel’tser, A V, Alikbayeva, L A, Zhirnov, A Yu, Andreyeva, M A, Gorshkova, M P, Antonova, M S

“…Introduction. To perform mass studies of the indoors air environment of the ammonium content the actual issues are the shortening of the sampling time and…”
Get more information

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria by Kaplan, Allen, MD, Ferrer, Marta, MD, PhD, Bernstein, Jonathan A., MD, Antonova, Evgeniya, MS, PhD, Trzaskoma, Benjamin, MS, Raimundo, Karina, MS, Rosén, Karin, MD, PhD, Omachi, Theodore A., MD, MBA, Khalil, Sam, PhD, Zazzali, James L., PhD, MPH

“…Background Few data are available that describe response patterns in patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU)…”
Get full text

Deep levels, transport and THz emission properties of SiGe/Si quantum-well structures by I. V. ANTONOVA M. S. KAGAN E. P. NEUSTROEV S. A. SMAGULOVA

“…Recharging of quantum confinement levels in SiGe quantum wells (QW) was studied by charge deep-level transient spectroscopy (Q-DLTS) for Si/SiGe/Si structures…”
Get full text

My Hives Diary: An Ios App to Track Urticaria Symptoms by Antonova, Evgeniya, MS, PhD, Raimundo, Karina, BPharm, MS, Zazzali, James, PhD

“…Methods The contents of this app are based on the Urticaria Patient Daily Diary (UPDD) used to assess CIU/CSU symptoms and their impact in three randomized…”
Get full text

Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab by Antonova, Evgeniya, MS, PhD, Trzaskoma, Benjamin, MS, Omachi, Theodore A., MD, MBA, Schatz, Michael, MD, MS, FAAAAI

“…Patients reported asthma control via the Asthma Control Test (ACT; well-controlled [ACT>19] vs poorly-controlled [ACT<=19]) and productivity impairment via the…”
Get full text

Study Design, Baseline and Open-Label Results from XTEND-CIU: A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab through 48 Weeks in Patients with Chronic Idiopathic Urticaria by Casale, Thomas B., MD, FAAAAI, Scarupa, Mark D., MD, Holden, Michael, MD, MS, Trzaskoma, Benjamin L., MS, Antonova, Evgeniya, MS, PhD, Win, Patrick H., MD

“…Conclusions A higher-than-expected number of patients responded to omalizumab during the 24-week open-label period and were eligible for randomization in the…”
Get full text

Allergen Sensitization Is Associated with Increased Rates of Exacerbations, Oral Corticosteroid (OCS) Use, and Asthma-Related Healthcare Services in Children with Severe or Poorly Controlled Asthma by Teague, W. Gerald, MD, Antonova, Evgeniya, MS, PhD, Kong, Amanda M., MPH, Ding, Yao, PhD, Iqbal, Ahmar, MD, Chipps, Bradley W., MD

“…Methods Children aged 6-11 with severe or poorly-controlled asthma (thereafter=asthma; >=2 asthma medical claims [ICD-9-CM 493.x; 1st diagnosis = ID], >=2…”
Get full text

Higher Immunoglobulin E (IgE) Levels Are Associated with Greater Emergency Care and Other Healthcare Utilization Among Asthma Patients in a Real-World Data Setting by Luskin, Allan T., MD, Antonova, Evgeniya, MS, PhD, Broder, Michael, MD, MSHS, Chang, Eunice, PhD, Omachi, Theodore A., MD, MBA

“…High-IgE patients were more likely to have used allergen immunotherapy (18.2% vs 10.9%; p=0.008), chronic oral corticosteroids (OCS) (33.6% vs 26.0%; p=0.034),…”
Get full text

Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab) by Chipps, Bradley W., MD, Busse, William, MD, Luskin, Allan T., MD, Zeiger, Robert S., MD, PhD, FAAAAI, Trzaskoma, Benjamin L., MS, Griffin, Noelle M., PhD, Antonova, Evgeniya, MS, PhD, Limb, Susan L., MD, Casale, Thomas B., MD, FAAAAI

“…Rationale Real-world data are important to supplement clinical trial data in heterogeneous diseases like asthma…”
Get full text

Clinically Significant Improvements in Asthma Patient-Reported Outcomes: Results from the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study by Gonzalez-Reyes, Erika G., MD, Luskin, Allan T., MD, Busse, William, MD, Casale, Thomas B., MD, FAAAAI, Chipps, Bradley E., MD, Antonova, Evgeniya, MS, PhD, Limb, Susan L., MD, Trzaskoma, Benjamin L., MS, Griffin, Noelle M., PhD, Zeiger, Robert S., MD, PhD, FAAAAI

“…Conclusions In a real world setting, patients receiving omalizumab reported at month 12, clinically meaningful improvement from baseline in asthma control,…”
Get full text

Corticosteroid-Related Adverse Events in Chronic Idiopathic Urticaria by Ledford, Dennis, MD, PhD, Broder, Michael, MD, MSHS, Antonova, Evgeniya, MS, PhD, Solari, Paul, MD, Omachi, Theodore A., MD, MBA, Chang, Eunice, PhD, Sun, Gordon H., MD, MS

“…AEs of interest included diabetes mellitus, hypertension, lipid disorders, cataracts, depression and mania, skeletal conditions (osteoporosis and fractures),…”
Get full text

Response Patterns in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Patients Treated with Omalizumab for 24 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Clinical Trials (ASTERIA I and GLACIAL) by Kaplan, Allen P., MD, FAAAAI, Antonova, Evgeniya, MS, PhD, Trzaskoma, Benjamin, MS, Raimundo, Karina, BPharm, MS, Rosén, Karin, MD, PhD, Omachi, Theodore A., MD, MBA, Khalil, Sam, PhD, Zazzali, James, Ph.D

“…Median time to response was not reached by W24 in other treatment arms…”
Get full text